e-CBT for Bipolar Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if electronic cognitive behavioral therapy (e-CBT) effectively helps individuals with Bipolar II Disorder experiencing depressive symptoms. Conducted online, e-CBT offers easier access to therapy compared to traditional in-person sessions. The study will compare two groups: one receiving e-CBT alongside their usual treatment and another continuing with only their usual treatment. Individuals diagnosed with Bipolar II Disorder, currently in a depressive phase, and with reliable internet access may be suitable candidates for this trial. As an unphased study, this trial provides a unique opportunity to access innovative therapy methods that could enhance mental health.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual treatment, as the study involves adding e-CBT to your existing care.
What prior data suggests that e-CBT is safe for treating Bipolar Disorder?
Research has shown that electronic Cognitive Behavioral Therapy (e-CBT) is generally easy for patients to manage. Studies have found that e-CBT is as effective as face-to-face CBT in treating depression and anxiety, including for those with bipolar disorder. A review of multiple studies found that e-CBT manages depressive symptoms in bipolar disorder as effectively as other online therapies.
No major reports of serious side effects have emerged from using e-CBT. As a form of talk therapy conducted online, it does not involve medication or physical procedures, reducing the risk of physical side effects. Overall, e-CBT is considered a safe option for mental health treatment.12345Why are researchers excited about this trial?
Researchers are excited about e-CBT for Bipolar Disorder because it offers a new, more accessible way to deliver cognitive-behavioral therapy. Unlike traditional in-person CBT, e-CBT is administered online through OPTT, allowing for flexible scheduling and broader reach to patients who might not have easy access to mental health services. The program features engaging multimedia modules and weekly personalized feedback from clinicians, which could streamline the therapy process and make it more efficient. This method not only saves time for healthcare providers but also ensures that patients receive tailored feedback, potentially enhancing the overall effectiveness of the treatment.
What evidence suggests that e-CBT is effective for treating Bipolar Disorder II with depressive symptoms?
Research has shown that electronic cognitive behavioral therapy (e-CBT), which participants in this trial may receive, can effectively manage depression in individuals with Bipolar II Disorder. Studies indicate that e-CBT works as well as face-to-face CBT for treating depression and anxiety, effectively reducing depressive episodes. One study found that e-CBT helps more people adhere to their therapy, which is crucial for those who struggle to attend regular sessions. Overall, e-CBT offers an easier way to access effective mental health care.12367
Who Is on the Research Team?
Nazanin Alavi
Principal Investigator
Queen's University
Are You a Good Fit for This Trial?
This trial is for individuals with Bipolar Disorder II (BAD-II) currently experiencing depressive symptoms. They must have reliable internet access, understand and speak English, and be able to consent to participate. People are excluded if they've had CBT in the last year, show active suicidal or homicidal thoughts, are in a hypomanic/manic phase, have acute psychosis or severe substance abuse issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive e-CBT through OPTT for 12 weeks, completing weekly modules and homework assignments
Follow-up
Participants are monitored for safety and effectiveness after treatment using MADRS, YMRS, and CGI-BP-M questionnaires
Open-label extension (optional)
Participants in the control group are offered the e-CBT program after the first 12 weeks
What Are the Treatments Tested in This Trial?
Interventions
- e-CBT
Trial Overview
The study tests electronic Cognitive Behavioural Therapy (e-CBT) using a secure platform called OPTT versus usual treatment for managing depression in BAD-II patients. It involves weekly modules and homework reviewed by clinicians over 12 weeks. The effectiveness will be measured through questionnaires and interviews.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
All e-CBT sessions will be administered through OPTT and will consist of approximately 30 slides per week. The content and format of each weekly online session will be designed to mirror in-person CBT for the treatment of BAD-II. Participants will complete the module and submit the assigned homework to their clinician through OPTT where the clinician will be able to provide personalized feedback. These pre-designed engaging and multimedia modules will be able to streamline the therapy process, helping care providers save time on repeating similar materials to all patients and focusing on delivering personalized feedback to each patient. The slides will highlight a different topic each week and include general information, an overview of skills, and homework that is to be completed within that week. All weekly sessions have an estimated completion time of 50 minutes. During the 12 weeks, both groups will continue with their TAU.
Participants will continue with treatment as usual and any lifestyle activities (diet, exercise, medication, etc.)
e-CBT is already approved in European Union, United States, Canada for the following indications:
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
- Depression
- Anxiety disorders
- Phobias
- PTSD
- Sleep disorders
- Eating disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Nazanin Alavi
Lead Sponsor
Dr. Nazanin Alavi
Lead Sponsor
Queen's University
Lead Sponsor
Online PsychoTherapy Clinic
Collaborator
Published Research Related to This Trial
Citations
Evaluating the Efficacy of Web-Based Cognitive Behavioral ...
Evaluating the Efficacy of Web-Based Cognitive Behavioral Therapy for the Treatment of Patients With Bipolar II Disorder and Residual Depressive ...
Evaluating the Efficacy of Web-Based Cognitive Behavioral ...
Evaluating the Efficacy of Web-Based Cognitive Behavioral Therapy for the Treatment of Patients With Bipolar II Disorder and Residual Depressive Symptoms: ...
Online cognitive behavioral therapy (eCBT) for the ...
McCraw et al. The duration of undiagnosed bipolar disorder: effect on outcomes and treatment response ... Cognitive Therapy and Positive ...
4.
bmcpsychiatry.biomedcentral.com
bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-025-06973-3Cognitive behavioural therapy in comparison to treatment as ...
The efficacy of cognitive-behavioral therapy in bipolar disorder: a quantitative meta-analysis. J Clin Psychiatry. 2010;71(1):66–72. Article ...
Efficacy of cognitive-behavioral therapy in patients with bipolar ...
A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry ...
Effectiveness of Web-Based Cognitive Behavioral Therapy for ...
This systematic review of randomized controlled trials (RCTs) aims to estimate the efficacy of several types of web-based interventions among patients with ...
The Efficacy of Computerized Cognitive Behavioral ...
The findings of this study suggest that the cCBT program we developed was an effective nonpharmacological treatment for symptoms of anxiety, depression, and ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.